Last chance to register for the biotech industry event of the year: AusBiotech 2013

Brisbane will welcome more than 1000 of the brightest brains in biotechnology and innovation next week for the official launch of the AusBiotech 2013 national conference; a premier event on the Australian and Asia-Pacific calendar.

This year’s conference features a stellar line-up of speakers from the biotechnology, biopharmaceutical, life science, business, investment, research and health industries, who will be exploring the conference’s central theme ‘Bio-economy in transition’.

The event is being held from 30 October- 1 November 2013, returning to Queensland for the first time since 2006.

As part of the conference launch, dignitaries and delegates will be able to tour the DSM Biologics Facility at Woolloongabba, which is the result of a major collaboration between global life sciences company DSM Biologics (the Netherlands), The University of Queensland’s Australian Institute for Bioengineering and Nanotechnology (AIBN) and the state government. The partnership involves the development of biologics, the next generation of human therapeutics.

The program can be viewed online at http://ausbiotechnc.org/program.

Must-see sessions at this year’s AusBiotech national conference

AusBiotech 2013 features a superb line-up of speakers. The Millis Oration will be delivered by Dr Mark Shackleton from the Melanoma Research Laboratory at Melbourne’s Peter MacCallum Cancer Centre, who will explore the ‘Implications of Cancer Heterogeneity for Cancer Treatment and Research’. He will discuss the fascinating layers of molecular evaluation now being undertaken to diagnose and effectively treat cancer.

Professor Göran Roos, Chair of the Advanced Manufacturing Council, will share his views for the advanced manufacturing sector and carefully evaluate what the future holds. He will review why manufacturing matters to an economy, the historical development of manufacturing and the role of biotechnology in securing its future.

Other intriguing drawcards include a closer look at the ‘Challenges of Establishing a Small Biotech Company’ with Professor Ian Frazer, CEO and Director of Research for the Translational Research Institute. Conversations around commercialisation will continue into the Asia market session, which will examine the many pursuits and potential projects that have emerged in the Year of the Snake.

Wine and dine with innovative minds

Tickets are now on sale for the AusBiotech - CSL Conference Dinner; one of the industry’s best opportunities to meet and mingle. Even if you can’t make it to the conference, the dinner is an excellent chance to network with the who’s who of innovation and, of course, to have plenty of fun too.

This year’s guest speaker is internationally acclaimed neurosurgeon Associate Professor Charlie Teo, Director of the Centre for Minimally Invasive Neurosurgery and Chairman of Neurosurgery at the Prince of Wales Private Hospital in Sydney. Teo has saved countless lives by attempting procedures others refused to touch. He epitomises innovation and excellence in his craft. Join him for one night only in Brisbane.

If you haven’t already registered for the conference and/or the dinner, go to http://ausbiotechnc.org/registration.